Cargando…
Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer
PURPOSE: Chemotherapy with anthracyclines, taxanes, or alkylating agents often causes cutaneous side effects. Nonspecific inhibition of the proliferative activity of keratinocytes has antidifferentiation effects that lead to defects in the barrier function and, thus, to dry, itchy, and irritable ski...
Autores principales: | Wohlrab, Johannes, Bangemann, Nikola, Kleine-Tebbe, Anke, Thill, Marc, Kümmel, Sherko, Grischke, Eva-Maria, Richter, Rainer, Seite, Sophie, Lüftner, Diana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126578/ https://www.ncbi.nlm.nih.gov/pubmed/25114589 http://dx.doi.org/10.2147/BCTT.S61699 |
Ejemplares similares
-
Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy
por: Lüftner, Diana, et al.
Publicado: (2018) -
Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?
por: Richter, Hannah, et al.
Publicado: (2018) -
Interest of Supportive and Barrier Protective Skin Care Products in the Daily Prevention and Treatment of Cutaneous Toxicity During Radiotherapy for Breast Cancer
por: Berger, Antoine, et al.
Publicado: (2018) -
Influence of Skin Subjective Symptoms on Sleep Quality in Patients with Cutaneous Disorders: A Study of 2871 Subjects
por: Halioua, Bruno, et al.
Publicado: (2021) -
Barrier function and microbiotic dysbiosis in atopic dermatitis
por: Seite, Sophie, et al.
Publicado: (2015)